STP
GH icon

Science & Technology Partners’s Guardant Health GH Stock Holding History

Science & Technology Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.3M Buy
+208,817
New +$22.7M 5.28% 2
2026
Q1 		– Sell
-35,860
Closed -$3.66M – 49
2025
Q4 		$3.66M Buy
+35,860
New +$3.21M 1.02% 21

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Science & Technology Partners's GH Position: Q2 2026 in Review

Science & Technology Partners opened a new position in Guardant Health (GH) in Q2 2026: 208,817 shares worth $31.3M. The stake represents 5.28% of the portfolio and ranks #2 among its holdings. This is a return to the name: Science & Technology Partners previously reported a position in GH as recently as Q4 2025.

Science & Technology Partners first reported a position in GH in Q4 2025 and has held it in 2 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Science & Technology Partners held 208,817 shares of Guardant Health worth $31.3M as of Q2 2026.
  • Guardant Health was a new Science & Technology Partners position in Q2 2026.
  • Guardant Health made up 5.28% of Science & Technology Partners's portfolio in Q2 2026, its #2 holding.
  • Science & Technology Partners first reported a position in Guardant Health in Q4 2025 and has held it in 2 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Science & Technology Partners's 13F filing for Q2 2026, filed 14 Aug 2026.